0000899243-19-030109.txt : 20191227 0000899243-19-030109.hdr.sgml : 20191227 20191227154155 ACCESSION NUMBER: 0000899243-19-030109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191224 FILED AS OF DATE: 20191227 DATE AS OF CHANGE: 20191227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLASKIN CHRISTINE M CENTRAL INDEX KEY: 0001288123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 191313645 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-24 0 0001098972 AGENUS INC AGEN 0001288123 KLASKIN CHRISTINE M C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 0 1 0 0 PFO and PAO Stock Option (Right to buy) 4.12 2019-12-24 4 A 0 85000 0.00 A 2029-12-24 Common Stock 85000 85000 D Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Option vests over a three-year period, with 1/3 of Option vesting on December 24, 2020, and the balance vesting in equal quarterly installments thereafter. /s/Evan D. Kearns, as Attorney-in-Fact for Christine M. Klaskin 2019-12-27